Records containing: Narcolepsy Type 2
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study results posted · 2026-06-30Behavioral Treatment of Narcolepsy-Related Nightmares
-
CLINICAL_TRIALS study record update · 2026-04-27A Phase 2a, Randomized, Double-blind, Placebo-controlled Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ORX750 in Subjects With Narcolepsy and Idiopathic Hypersomnia (CRYSTAL-1)
-
CLINICAL_TRIALS study record update · 2026-04-21A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 2 (Brilliance NT2 Study 303)
-
CLINICAL_TRIALS study record update · 2026-04-16A Phase 2, Long-term Extension Study of the Safety and Efficacy of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia Who Completed a Sponsored ORX750 Clinical Trial
-
CLINICAL_TRIALS study record update · 2026-03-18Improving Social Relationships for Adolescents With Central Disorders of Hypersomnolence
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-03-05Epidemiology of Narcolepsy Type 1 and Type 2 in Spain
-
CLINICAL_TRIALS study record update · 2026-03-04An Open-Label, Long-Term Extension Study to Investigate the Safety, Tolerability, and Durability of Treatment Effect of ALKS 2680 in Subjects With Narcolepsy Type 1 and Type 2 and Idiopathic Hypersomnia
-
CLINICAL_TRIALS study record update · 2026-02-27A Phase 2, Parallel-Group, Dose-Range-Finding Study With Randomized Double-Blind Treatment and Open-Label Periods to Evaluate the Safety and Efficacy of ALKS 2680 in Subjects With Narcolepsy Type 2
-
CLINICAL_TRIALS study record update · 2026-02-12A Randomized, Double-Blinded, Placebo-Controlled, Dose-Finding, Adaptive Trial to Evaluate the Safety, Tolerability, and Efficacy of TAK-360 in Participants With Narcolepsy Without Cataplexy (NT2)
-
CLINICAL_TRIALS study record update · 2025-10-29A Phase 2a, Randomized, Double-blind, Placebo-controlled Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ORX750 in Subjects With Narcolepsy and Idiopathic Hypersomnia (CRYSTAL-1)
-
CLINICAL_TRIALS study record update · 2025-01-09A Randomized, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of TAK-861 for the Treatment of Narcolepsy Without Cataplexy (Narcolepsy Type 2)
-
CLINICAL_TRIALS study record update · 2024-06-12Behavioral Treatment of Narcolepsy-Related Nightmares